Being diagnosed with a blood cancer can make you feel like you are alone. The Bloodline with LLS is here to remind you that after a diagnosis comes hope. Listen in as experts and patients guide listeners in understanding diagnosis, treatment, and resources available to blood cancer patients. Join Alicia Patten and Lizette Rivera from the Patient Access Education Team at The Leukemia & Lymphoma Society as they explore various survivorship topics.
To subscribe to The Bloodline with LLS, click here.
Treating Acute Lymphoblastic Leukemia
Join Alicia and Lizette as they speak with Dr. Mohammad Maher Abdul-Hay, a hematologist and bone marrow transplant physician in New York, New York who is affiliated with multiple hospitals including NYC Health and Hospitals, Bellevue, and NYU Langone Hospitals. On this episode, Dr. Abdul-Hay explains how ALL is treated and addresses pre-treatment considerations. He also shares the long-term effects of treatment and the importance of getting a second opinion and open communication between a patient and their healthcare team.
Click here to listen to our other episode with Dr. Mohammad Maher Abdul-Hay where he explains how ALL is diagnosed.
Support for this episode provided by Amgen and Takeda.
Treating Acute Myeloid Leukemia (AML)
There have been few advances in treatment for AML in 40 years. Why is acute myeloid leukemia (AML) so difficult to treat? What is the current treatment for AML? How is The Leukemia & Lymphoma Society (LLS) striving to change that? How are targeted therapies being used for patients? Is immediate treatment for patients necessary for all AML patients? How does a patient’s ethnic background play a role in finding a matching bone marrow donor?
Join Alicia and Lizette as they address these questions and more with Dr. Martha Arellano from Winship Cancer Institute of Emory University in Atlanta, Georgia. On this episode, Dr. Arellano addresses current treatment and treatment advances for AML, including stem cell transplantation and cellular therapy. She also explains the goal and impact of the Beat AML Master Trial, a groundbreaking collaborative and targeted clinical trial for patients with AML. Listen in as Dr. Arellano shares her excitement about the future of treatment for AML.
Support for this episode provided by Jazz Pharmaceuticals.
Adopting After Cancer: Dawn’s Story
As a junior in college and an intramural volleyball player who attributed the increasing pain in her right arm to the sport, Dawn Scott was forced to take notice when she woke up one day and realized that her arm was so swollen that she could not bend it. Although blood clots run in her family, there was a small voice that told her that it was something else. During her three-week admission time, she received her diagnosis of epithelioid hemangioendothelioma (EHE). Join in as Shona sits down with Dawn to discuss Dawn’s story and why Dawn believes fertility should be discussed between every patient and physician, even if the odds are slim. Although having a child naturally seemed unlikely, Dawn explored her other options and chose to pursue adoption. She shares her experience, advice she received from those around her, questions to ask, the differences she experienced between local and national adoption agencies, and how this experience has shaped her outlook on life. Hear Dawn’s story about how her and her husband, Brent, created the family they envisioned.
Support for The Bloodline with LLS provided by Amgen, Bristol-Myers Squibb, Jazz Pharmaceuticals, Kite Pharmaceuticals, Pharmacyclics, Seattle Genetics, and Takeda.
*The information contained in this podcast is for general information purposes only and is subject to change without notice. It is not intended to substitute the advice of your healthcare provider or information provided to you by your insurance carrier.
To listen to Treating Blood Cancers, our podcast for healthcare professionals, click here.